The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Chronic inflammation: a failure of resolution?
Open accessAbstract
Summary: Inflammation has evolved as a protective response to insult or injury, it's a primordial response that eliminates or neutralises foreign organisms or material, the resolution of inflammation encompasses the endogenous anti‐inflammatory mechanisms that protect us against excessive tissue injury and promote the restoration of tissue structure and function. In fact, our well being and survival depends upon its efficiency and carefully‐balanced control. In general, the innate inflammatory response initiates within minutes and, if all is well, resolves within hours. In contrast, chronic inflammation persists for weeks, months or even years. Here, we are going to discuss the key endogenous checkpoints necessary for mounting an effective yet limited inflammatory response and the crucial biochemical pathways necessary to prevent its persistence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mammalian MAP kinase signalling cascades
Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,111
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638 · cited 13×
“A20 is another inducible ubiquitin ligase, which functions as a negative feedback regulator of TLR and TNFR signalling to IKK and NF-jB.”
InfluentialKyriakis, J. M., & Avruch, J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.807 · Cited by 3,382
The two NF-κB activation pathways and their role in innate and adaptive immunity
Bonizzi, G., & Karin, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.03.008 · Cited by 2,535
The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases
Karin, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16483 · Cited by 2,431
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D. L., et al. (2004) · Nature · doi:10.1038/nature02794 · Cited by 1,856
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Activation and signaling of the p38 MAP kinase pathway
ZARUBIN, T., & HAN, J. (2005) · Cell Research · doi:10.1038/sj.cr.7290257 · Cited by 1,707
Signal transduction by tumor necrosis factor and its relatives
Baud, V., & Karin, M. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02064-5 · Cited by 1,655
Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2
Gantner, B. N., Simmons, R. M., Canavera, S. J., Akira, S., & Underhill, D. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021787 · Cited by 1,643
Lipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453 · cited 2×
“LXs display selective actions on leucocytes that include inhibition of PMN chemotaxis (Levy et al. 2001), PMN adhesion to and transmigration through endothelial cells (Papayianni et al.”
BackgroundHomozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
Botto, M., Dell' Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., & Walport, M. J. (1998) · Nature Genetics · doi:10.1038/ng0598-56 · Cited by 1,434
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
Rossi, A., Kapahi, P., Natoli, G., Takahashi, T., Chen, Y., Karin, M., & Santoro, M. G. (2000) · Nature · doi:10.1038/47520 · Cited by 1,310
The ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
Neel, B. G., Gu, H., & Pao, L. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00091-4 · Cited by 1,249 · cited 2×
“responsible for negative regulation of TK signalling (Neel et al. 2003).”
BackgroundInducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Self-citationO'Shea, J. J., Gadina, M., & Schreiber, R. D. (2002) · Cell · doi:10.1016/s0092-8674(02)00701-8 · Cited by 1,119
The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal
Kelliher, M. A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B. Z., & Leder, P. (1998) · Immunity · doi:10.1016/s1074-7613(00)80535-x · Cited by 1,102
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses
Boone, D. L., Turer, E. E., Lee, E. G., Ahmad, R.-C., Wheeler, M. T., Tsui, C., Hurley, P., Chien, M., Chai, S., Hitotsumatsu, O., et al. (2004) · Nature Immunology · doi:10.1038/ni1110 · Cited by 1,090
Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6
Häcker, H., Redecke, V., Blagoev, B., Kratchmarova, I., Hsu, L.-C., Wang, G. G., Kamps, M. P., Raz, E., Wagner, H., Häcker, G., et al. (2006) · Nature · doi:10.1038/nature04369 · Cited by 968
Huynh, M.-L. N., Fadok, V. A., & Henson, P. M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0211638 · Cited by 957
Innate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer
Karin, M., Lawrence, T., & Nizet, V. (2006) · Cell · doi:10.1016/j.cell.2006.02.016 · Cited by 942
Self-citationAnti-inflammatory lipid mediators and insights into the resolution of inflammation
Lawrence, T., Willoughby, D. A., & Gilroy, D. W. (2002) · Nature Reviews Immunology · doi:10.1038/nri915 · Cited by 862
Self-citationSevere impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4
Suzuki, N., Suzuki, S., Duncan, G. S., Millar, D. G., Wada, T., Mirtsos, C., Takada, H., Wakeham, A., Itie, A., Li, S., et al. (2002) · Nature · doi:10.1038/nature736 · Cited by 853
Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis
Savill, J., Dransfield, I., Hogg, N., & Haslett, C. (1990) · Nature · doi:10.1038/343170a0 · Cited by 846
Hurst, S. M., Wilkinson, T. S., McLoughlin, R. M., Jones, S., Horiuchi, S., Yamamoto, N., Rose-John, S., Fuller, G. M., Topley, N., & Jones, S. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00151-0 · Cited by 811
Heme oxygenase: A novel target for the modulation of inflammatory response
Willis, D., Moore, A. R., Frederick, R., & Willoughby, D. A. (1996) · Nature Medicine · doi:10.1038/nm0196-87 · Cited by 783
Inflammatory Resolution: new opportunities for drug discovery
Gilroy, D. W., Lawrence, T., Perretti, M., & Rossi, A. G. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1383 · Cited by 772
Self-citationPossible new role for NF-κB in the resolution of inflammation
Lawrence, T., Gilroy, D. W., Colville-Nash, P. R., & Willoughby, D. A. (2001) · Nature Medicine · doi:10.1038/nm1201-1291 · Cited by 749
Self-citationThe Healing Hand: Man and Wound in the Ancient World
LOEFFEL, E. D. (1975) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1975.03260230069032 · Cited by 731
Alexander, W. S., & Hilton, D. J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.091003.090312 · Cited by 701
Godson, C., Mitchell, S., Harvey, K., Petasis, N. A., Hogg, N., & Brady, H. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1663 · Cited by 638
IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation
Lawrence, T., Bebien, M., Liu, G. Y., Nizet, V., & Karin, M. (2005) · Nature · doi:10.1038/nature03491 · Cited by 626
Self-citationArch, R. H., Gedrich, R. W., & Thompson, C. B. (1998) · Genes & Development · doi:10.1101/gad.12.18.2821 · Cited by 608
Philippidis, P., Mason, J. C., Evans, B. J., Nadra, I., Taylor, K. M., Haskard, D. O., & Landis, R. C. (2004) · Circulation Research · doi:10.1161/01.res.0000109414.78907.f9 · Cited by 476 · cited 1×
“A potentially pro-resolution role for CD163 was demonstrated recently in both in vitro and in vivo models of resolving inflammation (Philippidis et al. 2004).”
BackgroundPhagocyte receptors for apoptotic cells: recognition, uptake, and consequences
Fadok, V. A., Bratton, D. L., & Henson, P. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14122 · Cited by 474
The Healing Hand: Man and Wound in the Ancient World
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-270_1 · Cited by 460
Immune recognition of fungal β-glucans
Brown, G. D., & Gordon, S. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00505.x · Cited by 420
From JNK to Pay Dirt: Jun Kinases, their Biochemistry, Physiology and Clinical Importance
Karin, M., & Gallagher, E. (2005) · IUBMB Life · doi:10.1080/15216540500097111 · Cited by 412
C1q and Systemic Lupus Erythematosus
Walport, M. J., Davies, K. A., & Botto, M. (1998) · Immunobiology · doi:10.1016/s0171-2985(98)80032-6 · Cited by 393
CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis.
Ren, Y., Silverstein, R. L., Allen, J., & Savill, J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1857 · Cited by 389
Bellingan, G. J., Caldwell, H., Howie, S. E., Dransfield, I., & Haslett, C. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.6.2577 · Cited by 378
Stabilization of Interleukin-2 mRNA by the c-Jun NH 2 -Terminal Kinase Pathway
Chen, C.-Y., Del Gatto–Konczak, F., Wu, Z., & Karin, M. (1998) · Science · doi:10.1126/science.280.5371.1945 · Cited by 348
Muppidi, J. R., Tschopp, J., & Siegel, R. M. (2004) · Immunity · doi:10.1016/j.immuni.2004.10.001 · Cited by 338
Park, J. M., Greten, F. R., Wong, A., Westrick, R. J., Arthur, J. S. C., Otsu, K., Hoffmann, A., Montminy, M., & Karin, M. (2005) · Immunity · doi:10.1016/j.immuni.2005.08.010 · Cited by 320
Dean, J. L. E., Sully, G., Clark, A. R., & Saklatvala, J. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.04.006 · Cited by 307
IKKβ Is Required for Prevention of Apoptosis Mediated by Cell-Bound but Not by Circulating TNFα
Maeda, S., Chang, L., Li, Z.-W., Luo, J.-L., Leffert, H., & Karin, M. (2003) · Immunity · doi:10.1016/s1074-7613(03)00301-7 · Cited by 286
McLoughlin, R. M., Witowski, J., Robson, R. L., Wilkinson, T. S., Hurst, S. M., Williams, A. S., Williams, J. D., Rose-John, S., Jones, S. A., & Topley, N. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17129 · Cited by 281 · cited 1×
“Studies addressing this issue of leucocyte infiltration in peritoneal inflammation have suggested that the interaction between IL-6 and its soluble receptor, sIL-6R, forms one of the major determinants of this switch from PMNs to monocytes (Hurst et al. 2001; McLoughlin et al. 2003).”
BackgroundMartin, M., Schifferle, R. E., Cuesta, N., Vogel, S. N., Katz, J., & Michalek, S. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.717 · Cited by 257
Papayianni, A., Serhan, C. N., & Brady, H. R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.6.2264 · Cited by 224
Serhan, C. N. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00047-3 · Cited by 205
Serhan, C. N. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0695-8 · Cited by 175
Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets
Ward, C., Dransfield, I., Chilvers, E. R., Haslett, C., & Rossi, A. G. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01391-7 · Cited by 168
Giles, K. M., Ross, K., Rossi, A. G., Hotchin, N. A., Haslett, C., & Dransfield, I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.976 · Cited by 164
Gilroy, D. W., Colville‐Nash, P., McMaster, S. K., Sawatzky, D. A., Willoughby, D. A., & Lawrence, T. (2003) · The FASEB Journal · doi:10.1096/fj.02-1162fje · Cited by 163
Self-citationHeasman, S. J., Giles, K., Ward, C., Rossi, A., Haslett, C., & Dransfield, I. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1780029 · Cited by 163
Goldblatt, D., & Thrasher, A. J. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01314.x · Cited by 155
Winzen, R., Gowrishankar, G., Bollig, F., Redich, N., Resch, K., & Holtmann, H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.4835-4847.2004 · Cited by 148
Bannenberg, G. L., Moussignac, R., Gronert, K., Devchand, P. R., Schmidt, B. A. R., Guilford, W. J., Bauman, J. G., Subramanyam, B., Perez, H. D., Parkinson, J. F., et al. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705912 · Cited by 140
Bellingan, G. J., Xu, P., Cooksley, H., Cauldwell, H., Shock, A., Bottoms, S. E., Haslett, C., Mutsaers, S. E., & Laurent, G. J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011794 · Cited by 131
Ward, C., Dransfield, I., Murray, J., Farrow, S. N., Haslett, C., & Rossi, A. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6232 · Cited by 131
Savill, J., Gregory, C. D., & Haslett, C. (2003) · Science · doi:10.1126/science.1092533 · Cited by 97
Hughes, J., Johnson, R. J., Mooney, A. F., Hugo, C., GORDON, K. L., & Savill, J. (1997) · Europe PMC (PubMed Central) · Cited by 92
Regulation of macrophage phagocytosis of apoptotic neutrophils by adhesion to fibronectin.
McCutcheon, J. C., Hart, S. P., Canning, M., Ross, K. A., Humphries, M. J., & Dransfield, I. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.5.600 · Cited by 50
Serhan, C. N., Takano, T., Clish, C. B., Gronert, K., & Petasis, N. A. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4793-8_42 · Cited by 23
Cited by
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
The Nuclear Factor NF- B Pathway in Inflammation
Lawrence, T. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001651 · Cited by 4,898
Self-citationChronic Inflammation in Obesity and the Metabolic Syndrome
Monteiro, R., & Azevedo, I. (2010) · Mediators of Inflammation · doi:10.1155/2010/289645 · Cited by 1,186
“However, if the neutralization and removal of the noxious stimuli or even if the clearance of apoptotic inflammatory cells from the inflamed tissue fail, the inflammatory process persists and a state of chronic inflammation or autoimmunity may arise with different agents being recruited, namely, T lymphocytes and the…”
BackgroundMacrophage death and defective inflammation resolution in atherosclerosis
Tabas, I. (2010) · Nature Reviews Immunology · doi:10.1038/nri2675 · Cited by 1,120
Resolution of Inflammation: What Controls Its Onset?
Sugimoto, M. A., Sousa, L. P., Pinho, V., Perretti, M., & Teixeira, M. M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00160 · Cited by 638
Metadata
- Authors
- Lawrence, T., & Gilroy, D. W.
- Venue
- International Journal of Experimental Pathology
- Publisher
- Wiley
- Published
- 2006-12-08
- Volume
- 88
- Issue
- 2
- Pages
- 85-94
- ISSN
- 0959-9673 (ISSN-L)
- 1365-2613
- OpenAlex
- W2146282578
- Cited by
- 372
- References
- 65
- FWCI
- 9.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.